CHUGAI PHARMACEUTICAL CO LTD

Chugai Pharmaceutical’s 2.74% rally shows resilient growth driven by a robust oncology pipeline and global partnerships, positioning it as a strong defensive play in Japan’s healthcare market.

Chugai Pharmaceutical’s 1.58% rise to JPY 6,795 signals a rebound amid Japanese equity volatility, showing why the firm’s pipeline and earnings are outpacing peers.